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Abstract
Background: Extramedullary plasmacytoma is a plasma cell neoplasm that presents as a solitary lesion in soft
tissue. Most extramedullary plasmacytomas involve the nasopharynx or upper respiratory tract. Primary
plasmacytoma of the stomach is extremely rare.
Case presentation: A 78-year-old Korean woman presented with epigastric pain for 3 months. She had a
history of an intractable gastric ulcer despite repeated endoscopic biopsies and appropriate medical therapy
for the ulcer. She underwent another endoscopy and a biopsy was performed for multiple large and deep
specimens. Ultimately, primary gastric plasmacytoma was confirmed. However, she and her attendant refused
standard local radiotherapy or surgical resection. She came to our emergency room 3 months later with hematemesis
due to a large gastric ulcer, despite management with medication for over 3 months at a local clinic. We again
recommended local radiation or surgical resection. However, as she was willing to undergo only medical therapy,
she was prescribed high-dose dexamethasone. Surprisingly, her ulcer completely regressed and remission was
maintained for over 1 year.
Conclusions: We report successful treatment of a rare primary gastric plasmacytoma mimicking intractable ulcer
by using high-dose dexamethasone. To the best of our knowledge, this is the first reported case successfully treated
with only high-dose dexamethasone.
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Background
Plasma cell neoplasms are commonly divided into four
groups: multiple myeloma (MM), plasma cell leukemia,
solitary plasmacytoma of the bone (SPB), and extrame-
dullary plasmacytoma (EMP) [1]. Most EMPs involve
the upper respiratory tract, including the sinuses, nasal
cavity, and nasopharynx; isolated primary plasmacy-
toma of the stomach is extremely rare [2].
Case presentation
A 78-year-old Korean woman presented with a com-
plaint of epigastric pain for 3 months. She was diagnosed
with atrial fibrillation and ejection fraction-preserved
heart failure 5 years earlier. She received regular follow-
up observations and took aspirin.
She initially underwent an endoscopy at our clinic
and was found to have extensive mucosal erythema
with an ulcer crater at the antrum. Pathologic find-
ings revealed chronic gastritis without Helicobacter
pylori colonization. She underwent gastric ulcer ther-
apy including a proton pump inhibitor (PPI). After 1
month, a follow-up endoscopy showed an unchanged
ulcer. A repeat biopsy examination revealed chronic
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inflammation without H. pylori colonization. She was
prescribed another PPI with a regimen for H. pylori
eradication (metronidazole, clarithromycin, PPI). How-
ever, her epigastric symptoms continued and she left
our hospital.
A follow-up endoscopy performed 2 months later,
despite appropriate and sufficient medical therapy in
our clinic for over 3 months, showed no interval
change (Fig. 1a).
An endoscopic biopsy was performed to produce
multiple large and deep specimens to differentiate
other diseases. Pathologic findings showed dense plas-
macytic proliferation of small mature lymphocytic
cells; these proliferative cells stained immunohisto-
chemically positive for lambda light chains and negative
for kappa chains, suggesting plasmacytoma (Fig. 2).
Therefore, we evaluated the patient for MM with a
bone marrow biopsy and considered serum monoclo-
nal gammopathy. However, she had no evidence of
bone marrow involvement with plasmacytoma or any
monoclonal gammopathy through electrophoresis and
immunofixation.
We concluded that she had primary gastric plasma-
cytoma; we recommended local radiotherapy or surgi-
cal resection. However, she and her attendant refused
further treatment due to old age and limited finances.
She came to our emergency room 3 months later
because of hematemesis due to a large gastric ulcer, des-
pite PPI treatment for over 3 months at a local clinic
(Fig. 1b). We performed endoscopic hemocoagulation
with high-dose PPI and tranexamic acid. We again rec-
ommended local radiation or surgical resection, but she
still declined extensive treatment. Therefore, we recom-
mended high-dose dexamethasone (40 mg daily for 4
days every 3 weeks) to be administered intravenously to
control the plasmacytoma, and she accepted.
After 2 weeks of high-dose dexamethasone, an endos-
copy revealed marked healing of her ulcer (Fig. 1c).
After a total of four cycles of high-dose dexamethasone,
the ulcer was not apparent on endoscopy (Fig. 1d). The
patient underwent a total of six cycles of high-dose
dexamethasone. One year later, no ulcer was observed
on endoscopy.
Discussion
EMP is a mass of neoplastic monoclonal plasma cells
that presents as a solitary lesion in a soft tissue other
than the bone. It is uncommon and accounts for ap-
proximately 3 % of all plasma cell neoplasms [2].
On endoscopy, gastric plasmacytoma usually appears
either as an ulcerated mass or as a discrete ulcer with
thickened gastric folds. Thus, it must be differentiated
from gastric ulcer, gastric adenocarcinoma, or lymph-
oma, in particular from mucosa-associated lymphoid tis-
sue (MALT) lymphoma [3, 4]. This case initially revealed
extensive mucosal erythema with an ulcer crater and
then changed into a large bleeding ulcer.
Fig. 1 Endoscopic finding. a Extensive mucosal erythema with an ulcer crater at the antrum was seen. b A large gastric ulcer with a bleeding
spot at the antrum was seen 3 months later. c After 2 weeks of high-dose dexamethasone, the ulcer lesion showed marked healing. d After four
cycles of high-dose dexamethasone, a healed ulcer scar replaced the ulcer lesion
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On pathological examination, a gastric plasmacytoma
shows the typical morphologic finding of plasma cell
proliferation with immunohistochemistry demonstration
of monoclonal light (kappa or lambda) or heavy chains
(immunoglobulin G, A, or M). The final diagnosis of pri-
mary gastric plasmacytoma is made by histologic con-
firmation of a single lesion in the stomach without bone
lesions, no evidence of plasma malignancy in the bone
marrow, and no monoclonal gammopathy [5, 6].
Usually, most EMPs present at an upper respiratory
site and are hard to resect completely due to inva-
siveness; thus, surgery is not recommended for initial
treatment. EMP is highly sensitive to radiotherapy;
thus, local radiotherapy is the first choice for EMP
due to its significant curative potential and lower
relapse rate [1].
Currently, there are no general guidelines for the treat-
ment of primary gastric plasmacytoma; however, local
radiotherapy may be superior to surgery in plasmacyto-
mas of the stomach due to organ preservation [7, 8].
If primary gastric plasmacytoma only involves the
submucosa of the stomach, endoscopic submucosal
resection can be another treatment option. If the re-
sult of a test for H. pylori is positive, then eradication
may be an alternative treatment [9, 10]. Recently, bor-
tezomib, which acts as an inhibitor of the ubiquitin–
proteasome pathway, alone or in combination with
dexamethasone proved effective in the management of
extramedullary relapse of MM, and might be an alter-
native treatment [11].
EMP usually behaves like an indolent disease be-
cause of its tendency to localize and it shows a low
rate of progression to MM. The prognosis of gastric
plasmacytoma is not well understood. However, EMP
has a favorable prognosis with a 70 % disease-free
survival at 10 years; the 10-year rate of progression of
EMP to MM ranges from 11 to 30 % [12, 13]. In this
case, our patient and her attendant refused local
radiotherapy and surgery due to old age and limited
finances; however, she was refractory to ulcer medica-
tion and had a life-threatening condition. Therefore,
we only used high-dose dexamethasone and the large
refractory ulcer showed dramatic regression.
Conclusions
This is the report of a case of an intractable gastric ulcer,
despite repeated endoscopic biopsies and sufficient gastric
ulcer therapy, which was finally confirmed as a primary
gastric plasmacytoma through deep multiple endoscopic
biopsies. The patient only accepted high-dose dexa-
methasone despite the recommendation of standard
local radiotherapy or surgical resection. The intractable
and life-threatening ulcer completely regressed and remis-
sion was maintained for over 1 year. This case was rare
and to the best of our knowledge it is the first report of
successful treatment using only high-dose dexamethasone.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
Fig. 2 a, b On microscopic examination, a large amount of lymphoplasmacytic proliferation and infitration (arrow) was observed (a, ×200;
b, ×400). c, d On immunohistologic examination, tumor cells were negative for kappa stain (c, ×400) but positive for lambda stain (d, ×400)
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images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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